lavender sky health tirzepatide pricing GLP-1 Agonists | Summer 2026 Survey Results! :

It strengthens your skins defense system by neutralizing harmful free radicals

received speaker honoraria from Novo Nordisk

The development of melanoma is thought to be rare, although a recent case report was published of a 64-year-old woman who developed nodular achromic melanoma within a nevus spilus [71]

Read full press release: #psoriasis #autoimmunediseases #clinicaltrial #clinicalresults #diseasemodifying #safety #tolerability #efficacy To view or add a comment, sign in selectION Therapeutics Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease - Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients - si-544 is the first highly potent and selective Kv1.3 blocker to safely achieve patient plasma levels suitable for high target engagement - Excellent safety and tolerability consistent with prior clinical experience